THE APEX TIMES
Bloomberg reported that Coinbase is aiming for a mid-2027 timeline to create its own “event contracts” for prediction markets. The company has not confirmed the reported schedule.
Coinbase, the largest U.S. crypto exchange by market structure, is reportedly working toward a new approach for the prediction markets it lists, including a goal to write its own event contracts by the middle of 2027, according to Bloomberg. The company’s exchanges currently support prediction markets through Kalshi, a third-party platform that structures many of the listed contract terms, a setup that can limit how quickly a listing operator changes product design.
The term “event contracts” in prediction markets refers to standardized agreements that pay out based on whether a defined real-world event occurs (for example, whether a specific outcome happens by a certain date). In many market designs, the party that drafts these contracts shapes the definitions, timing, settlement procedures, and other structural details that traders and regulators care about.
Bloomberg’s report frames Coinbase’s potential move as an evolution in how its prediction-market products are produced and managed. The report, as relayed in a later write-up by Yahoo Finance, suggests Coinbase wants more control over the underlying contract-writing function rather than relying as heavily on an external partner for the contract text and structure.
Coinbase has not publicly confirmed the timeline. The account of Bloomberg’s reporting also states that Coinbase did not validate the mid-2027 target in connection with the proposal, leaving open whether the plan is aspirational, the product scope could change, or the company could use a different schedule or operational model.
The backdrop is that prediction markets remain a high-scrutiny segment of the financial technology ecosystem. While the mechanics resemble trading, the products are tethered to real-world outcomes and therefore require careful definition, contract design, and settlement rules. Any shift in who drafts those contract terms can have second-order effects, including how quickly new events can be listed and how disputes are handled when outcomes are ambiguous.
For Coinbase, writing its own event contracts could be a strategic lever. If the company controls more of the contract “plumbing,” it may be able to iterate on product offerings faster, adapt to regulatory and compliance requirements, and potentially standardize contract templates across multiple event types. It also could reduce dependence on a single third-party drafting model, though the extent of any change would depend on how Coinbase and any partners divide responsibilities.
Even if Coinbase’s contract-writing plan proceeds, traders and observers are likely to focus on what would change for existing market listings and customers. The reported timeline does not clarify whether Coinbase would fully replace Kalshi’s role in drafting or whether Kalshi would remain involved in contract design, auditing, or approval. It also does not specify how new contract templates would be governed or what consumer-facing documentation would look like after any transition.
What is not disclosed in the reporting is equally important. Coinbase has not provided details on scope, such as which event categories would be drafted first, how settlement would be handled for edge cases, or whether the company would require additional approvals for any new contract structures. The company also has not shared whether the mid-2027 target is contingent on regulatory outcomes, internal system readiness, or partner negotiations.
A market-focused note argues the company’s cash-return profile could matter as Wall Street debates whether 2027 can resemble 2022. The company, however, did not provide new disclosure in the cited post.
A market report said the U.S. Securities and Exchange Commission has opened an investigation involving Nvidia as the chipmaker absorbs fallout from a sharp selloff. Investors now have to parse what the agency is looking at and how much the matter could weigh on disclosures and governance.
A reported Phase 3 win for Moderna’s personalized melanoma therapy, used alongside Merck’s Keytruda, is prompting fresh optimism that the mRNA platform can expand beyond infectious disease. Still, key details such as magnitude of benefit and full trial disclosure remain to be validated.
Marques Brownlee said he has placed an order for Tesla’s Cybercab following a 2024 challenge, and Tesla CEO Elon Musk replied “fair enough,” saying he would accept delivery.
A new market read on Booz Allen Hamilton Holding points to a sizable gap between the company’s valuation and the cash flow the business can generate, sharpening questions for investors about how durable profits and cash generation are in the defense IT services market.
The company is pursuing Australian National Immunisation Program listings for its mRNA influenza vaccines after securing a March 2027 agenda spot with the PBAC, a key committee that advises public reimbursement.
A newly announced partnership between Microsoft and Danaher aims to pair AI-assisted capabilities with cloud-based scientific instruments and lab software, including early tools that are already moving toward commercial use.
A new market round-up from Yahoo Finance highlights how lingering discussion among Fed officials about whether interest rates need to rise again can reshape expectations for large, consumer-facing companies like PepsiCo.
The initiative, launched within Aetna, is designed to link a large share of expectant members and their newborns to coordinated maternal and infant care. CVS Health has not, in the reporting, disclosed staffing, clinical protocols, or outcome targets tied to the program.
A fresh round of holiday changes at Target centers on shopping hours and promotions, a shift the company is indicating as part of how it intends to drive demand into the end of the year.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...